| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 3.65e-05 | 891 | 10 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 1.45e-04 | 1189 | 10 | 5 | GO:0046914 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 3.93e-04 | 60 | 10 | 2 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 4.07e-04 | 61 | 10 | 2 | GO:0098531 | |
| Domain | VitD_rcpt | 2.34e-05 | 14 | 10 | 2 | IPR000324 | |
| Domain | ZF_ZZ_1 | 3.93e-05 | 18 | 10 | 2 | PS01357 | |
| Domain | ZF_ZZ_2 | 3.93e-05 | 18 | 10 | 2 | PS50135 | |
| Domain | ZZ | 3.93e-05 | 18 | 10 | 2 | PF00569 | |
| Domain | VWC_out | 4.39e-05 | 19 | 10 | 2 | SM00215 | |
| Domain | ZnF_ZZ | 4.39e-05 | 19 | 10 | 2 | SM00291 | |
| Domain | Znf_ZZ | 4.39e-05 | 19 | 10 | 2 | IPR000433 | |
| Domain | VWC | 9.68e-05 | 28 | 10 | 2 | PF00093 | |
| Domain | VWFC_1 | 1.61e-04 | 36 | 10 | 2 | PS01208 | |
| Domain | VWC | 1.80e-04 | 38 | 10 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.80e-04 | 38 | 10 | 2 | PS50184 | |
| Domain | VWF_dom | 2.20e-04 | 42 | 10 | 2 | IPR001007 | |
| Domain | zf-C4 | 2.64e-04 | 46 | 10 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.64e-04 | 46 | 10 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 2.64e-04 | 46 | 10 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 2.64e-04 | 46 | 10 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 2.64e-04 | 46 | 10 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.64e-04 | 46 | 10 | 2 | PS51030 | |
| Domain | - | 2.75e-04 | 47 | 10 | 2 | 1.10.565.10 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.87e-04 | 48 | 10 | 2 | IPR000536 | |
| Domain | Hormone_recep | 2.87e-04 | 48 | 10 | 2 | PF00104 | |
| Domain | HOLI | 2.87e-04 | 48 | 10 | 2 | SM00430 | |
| Domain | - | 4.05e-04 | 57 | 10 | 2 | 3.30.50.10 | |
| Domain | Znf_NHR/GATA | 4.20e-04 | 58 | 10 | 2 | IPR013088 | |
| Domain | Growth_fac_rcpt_ | 2.99e-03 | 156 | 10 | 2 | IPR009030 | |
| Domain | - | 8.13e-03 | 261 | 10 | 2 | 1.10.238.10 | |
| Domain | EF-hand-dom_pair | 9.76e-03 | 287 | 10 | 2 | IPR011992 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 7.04e-05 | 38 | 5 | 2 | MM15865 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 7.04e-05 | 38 | 5 | 2 | M39657 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.13e-04 | 48 | 5 | 2 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.38e-04 | 53 | 5 | 2 | M8276 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 2.66e-02 | 768 | 5 | 2 | MM14851 | |
| Pubmed | 4.65e-07 | 1285 | 10 | 6 | 35914814 | ||
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.40e-05 | 18 | 6 | 2 | 91 | |
| GeneFamily | Nuclear hormone receptors | 1.07e-04 | 49 | 6 | 2 | 71 | |
| Coexpression | KANG_DOXORUBICIN_RESISTANCE_DN | 2.23e-05 | 19 | 10 | 2 | M3323 | |
| Coexpression | MTOR_UP.V1_DN | 3.81e-05 | 182 | 10 | 3 | M2670 | |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 5.05e-05 | 200 | 10 | 3 | M9161 | |
| Coexpression | GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP | 5.05e-05 | 200 | 10 | 3 | M7856 | |
| Coexpression | GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN | 1.44e-03 | 151 | 10 | 2 | M369 | |
| Coexpression | GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP | 1.59e-03 | 159 | 10 | 2 | M8814 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN | 1.59e-03 | 159 | 10 | 2 | M2983 | |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 1.59e-03 | 159 | 10 | 2 | M6502 | |
| Coexpression | GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP | 1.61e-03 | 160 | 10 | 2 | M6863 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_TCONV_DN | 1.71e-03 | 165 | 10 | 2 | M2960 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN | 1.71e-03 | 165 | 10 | 2 | M353 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 1.74e-03 | 166 | 10 | 2 | M6701 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP | 1.90e-03 | 174 | 10 | 2 | M8120 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 1.93e-03 | 175 | 10 | 2 | M6690 | |
| Coexpression | PGF_UP.V1_DN | 2.26e-03 | 190 | 10 | 2 | M2673 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.29e-03 | 191 | 10 | 2 | MM17059 | |
| Coexpression | GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP | 2.41e-03 | 196 | 10 | 2 | M8161 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 2.41e-03 | 196 | 10 | 2 | M4244 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.41e-03 | 196 | 10 | 2 | M3008 | |
| Coexpression | GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP | 2.41e-03 | 196 | 10 | 2 | M8683 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_UP | 2.43e-03 | 197 | 10 | 2 | M9537 | |
| Coexpression | GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP | 2.46e-03 | 198 | 10 | 2 | M5083 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP | 2.46e-03 | 198 | 10 | 2 | M4418 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN | 2.46e-03 | 198 | 10 | 2 | M5171 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 2.48e-03 | 199 | 10 | 2 | M9238 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN | 2.48e-03 | 199 | 10 | 2 | M6157 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 2.48e-03 | 199 | 10 | 2 | M9214 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP | 2.48e-03 | 199 | 10 | 2 | M4494 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 2.48e-03 | 199 | 10 | 2 | M6660 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 2.48e-03 | 199 | 10 | 2 | M3583 | |
| Coexpression | GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN | 2.48e-03 | 199 | 10 | 2 | M4673 | |
| Coexpression | GSE45365_NK_CELL_VS_CD11B_DC_UP | 2.48e-03 | 199 | 10 | 2 | M10030 | |
| Coexpression | GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP | 2.48e-03 | 199 | 10 | 2 | M9754 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP | 2.48e-03 | 199 | 10 | 2 | M9531 | |
| Coexpression | GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP | 2.48e-03 | 199 | 10 | 2 | M3050 | |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP | 2.48e-03 | 199 | 10 | 2 | M324 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP | 2.48e-03 | 199 | 10 | 2 | M6986 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN | 2.50e-03 | 200 | 10 | 2 | M3747 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP | 2.50e-03 | 200 | 10 | 2 | M9276 | |
| Coexpression | GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP | 2.50e-03 | 200 | 10 | 2 | M9278 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP | 2.50e-03 | 200 | 10 | 2 | M6158 | |
| Coexpression | GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M8869 | |
| Coexpression | GSE7852_THYMUS_VS_FAT_TCONV_DN | 2.50e-03 | 200 | 10 | 2 | M5750 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN | 2.50e-03 | 200 | 10 | 2 | M3579 | |
| Coexpression | GSE14308_TH2_VS_TH17_UP | 2.50e-03 | 200 | 10 | 2 | M3361 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN | 2.50e-03 | 200 | 10 | 2 | M9373 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP | 2.50e-03 | 200 | 10 | 2 | M3838 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN | 2.50e-03 | 200 | 10 | 2 | M8076 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN | 2.50e-03 | 200 | 10 | 2 | M9311 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 2.50e-03 | 200 | 10 | 2 | M5676 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c10-IFNG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.45e-04 | 126 | 10 | 2 | d19382597ce5c6546731ac1fd33c7dcb7916b2ea | |
| ToppCell | BAL-Severe-cDC_6|Severe / Compartment, Disease Groups and Clusters | 3.67e-04 | 130 | 10 | 2 | 4104d1e10609331b67db3b85c63537aec58b1713 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 138 | 10 | 2 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-04 | 138 | 10 | 2 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 5.21e-04 | 155 | 10 | 2 | 85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 5.55e-04 | 160 | 10 | 2 | a1bf6ed365cbc1ddb57c132a42dbe6485d45f544 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.69e-04 | 162 | 10 | 2 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Col23a1_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.12e-04 | 168 | 10 | 2 | 3fe432267656aff81b6d92c18d1b6fc0cde73d6a | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.56e-04 | 174 | 10 | 2 | ccc79febfcf588d8294ffc712338be96de8a5033 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.71e-04 | 176 | 10 | 2 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-04 | 178 | 10 | 2 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | severe-CD8+_T_naive|severe / disease stage, cell group and cell class | 7.01e-04 | 180 | 10 | 2 | 94fe530367b170777f4051a4034cff06d80dbb83 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-04 | 180 | 10 | 2 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 7.41e-04 | 185 | 10 | 2 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-04 | 186 | 10 | 2 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-04 | 186 | 10 | 2 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.73e-04 | 189 | 10 | 2 | 610d7cc1fc923dbd67d3b71f94d529a658982f87 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 7.81e-04 | 190 | 10 | 2 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.89e-04 | 191 | 10 | 2 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.97e-04 | 192 | 10 | 2 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.97e-04 | 192 | 10 | 2 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.05e-04 | 193 | 10 | 2 | beb862d38b88572836b0a797c8efef7a2492e0b9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.05e-04 | 193 | 10 | 2 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.05e-04 | 193 | 10 | 2 | c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.05e-04 | 193 | 10 | 2 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.05e-04 | 193 | 10 | 2 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.05e-04 | 193 | 10 | 2 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | 2507f6dc7f1fe8b91fe1e24497d26d05afc3cd21 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 8.14e-04 | 194 | 10 | 2 | 390bf41cccfd586725a2fe653a299a78e261ec9b | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-04 | 194 | 10 | 2 | 95dfbd9d9b8a47801edcfc35fb0d685901dcd2f8 | |
| ToppCell | COVID-19_Severe-CD4+_T_activated|World / disease group, cell group and cell class | 8.22e-04 | 195 | 10 | 2 | 61d2d6c2d59799b3d877e622ccbcee9e84703a35 | |
| ToppCell | (3)_Chondrocytes-(34)_Chondro-progen|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.22e-04 | 195 | 10 | 2 | d00cb2fab25f2026a9668a7f0686938a2e7155e2 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.22e-04 | 195 | 10 | 2 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID-19-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 8.30e-04 | 196 | 10 | 2 | 28515d8e2f02366fa0ac1bea251a7a3f659c98c7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-04 | 196 | 10 | 2 | 5159d8625d80c20eb28157b2603c8bde9d377a35 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.30e-04 | 196 | 10 | 2 | 6b5b7dbcb2cce8a736e44145a01290905876a5e9 | |
| ToppCell | (3)_Chondrocytes-(34)_Chondro-progen|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.39e-04 | 197 | 10 | 2 | 012c49a57f9c2a3dfa988cd3882c8c6b7ef3a5ad | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-Treg|ICU-NoSEP / Disease, condition lineage and cell class | 8.47e-04 | 198 | 10 | 2 | 1ed4dfe5565328cb0f7ef31e6b2f67dfbdf3e2ac | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.47e-04 | 198 | 10 | 2 | e9f434bfd072e590fe44d518057ee5aa653038f3 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-04 | 199 | 10 | 2 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-CD8+_Tcm|ICU-NoSEP / Disease, condition lineage and cell class | 8.56e-04 | 199 | 10 | 2 | 1df6d3dfb90e804cf65dc4dcb1c51d5974abfbab | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.56e-04 | 199 | 10 | 2 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 8.56e-04 | 199 | 10 | 2 | fd75dccb37d96448edf72b7d042b06833d4ead24 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 8.64e-04 | 200 | 10 | 2 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-04 | 200 | 10 | 2 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-04 | 200 | 10 | 2 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-04 | 200 | 10 | 2 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.64e-04 | 200 | 10 | 2 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 1.12e-06 | 198 | 10 | 4 | 3814_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.57e-05 | 190 | 10 | 3 | 3629_UP | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 7.10e-05 | 195 | 10 | 3 | 596_UP | |
| Drug | NU1025; Down 200; 100uM; MCF7; HG-U133A | 7.32e-05 | 197 | 10 | 3 | 608_DN | |
| Drug | Tacrine hydrochloride hydrate [1684-40-8]; Up 200; 15.8uM; PC3; HT_HG-U133A | 7.43e-05 | 198 | 10 | 3 | 6698_UP | |
| Drug | Imidurea [39236-46-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 7.54e-05 | 199 | 10 | 3 | 5481_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 7.54e-05 | 199 | 10 | 3 | 4749_UP | |
| Drug | Glutethimide, para-amino [125-84-8]; Up 200; 17.2uM; HL60; HT_HG-U133A | 7.66e-05 | 200 | 10 | 3 | 2390_UP | |
| Drug | helium | 3.45e-04 | 64 | 10 | 2 | CID000023987 | |
| Drug | CPDS | 3.89e-04 | 68 | 10 | 2 | CID000085040 | |
| Drug | D dB | 4.99e-04 | 77 | 10 | 2 | CID006437867 | |
| Drug | lead arsenate | 6.66e-04 | 89 | 10 | 2 | CID000024572 | |
| Drug | hexamethylmelamine | 8.74e-04 | 102 | 10 | 2 | CID000002123 | |
| Drug | dl-cystine | 1.37e-03 | 128 | 10 | 2 | CID000000595 | |
| Drug | AC1NRBPQ | 1.57e-03 | 137 | 10 | 2 | CID005288569 | |
| Drug | glyceraldehyde-3-phosphate | 2.10e-03 | 159 | 10 | 2 | CID000000729 | |
| Drug | AC124 | 2.48e-03 | 173 | 10 | 2 | CID000000253 | |
| Drug | ecdysone | 2.62e-03 | 178 | 10 | 2 | CID000019212 | |
| Drug | Triamterene [396-01-0]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.65e-03 | 179 | 10 | 2 | 1819_UP | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A | 2.68e-03 | 180 | 10 | 2 | 1152_DN | |
| Drug | Ebna | 2.77e-03 | 183 | 10 | 2 | CID000018835 | |
| Drug | Monensin sodium salt [22373-78-0]; Up 200; 5.8uM; PC3; HT_HG-U133A | 2.77e-03 | 183 | 10 | 2 | 3704_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 2.86e-03 | 186 | 10 | 2 | 4463_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.89e-03 | 187 | 10 | 2 | 1218_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 2.95e-03 | 189 | 10 | 2 | 6966_UP | |
| Drug | radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.98e-03 | 190 | 10 | 2 | 836_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; HL60; HT_HG-U133A | 2.98e-03 | 190 | 10 | 2 | 1172_DN | |
| Disease | cognitive function measurement | 1.06e-02 | 1434 | 10 | 3 | EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVCSCQNGFVMCRRM | 661 | Q99435 | |
| QNGFVMCRRMVCDCE | 666 | Q99435 | |
| MRFFCARCCSFGPEM | 1 | Q99972 | |
| GDMFRMDNCRFCRCQ | 346 | Q9NZV1 | |
| CRCESMMGFRYRCQQ | 246 | O60941 | |
| CSIMRMNRNRCQQCR | 146 | Q14995 | |
| CQMDAFMRRKCQQCR | 131 | P55055 | |
| EGCNRMSCRCGAQMC | 686 | Q9NWF9 | |
| NGFRCMACCRVFTTM | 226 | A1A519 | |
| EQFFLMCTRCCMGHR | 1336 | O00507 | |
| GRRMNCNVCDDFDLC | 1841 | O43149 |